(Q38122004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Giuseppina Opinto

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Annalisa Natalicchio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

16 July 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

Archives of Physiology and Biochemistry

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

170-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

Incretin hormone secretion over the day.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Obesity may attenuate the HbA1c-lowering effect of sitagliptin in Japanese type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

The glucagon-like peptides: pleiotropic regulators of nutrient homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Secretion and dipeptidyl peptidase-4-mediated metabolism of incretin hormones after a mixed meal or glucose ingestion in obese compared to lean, nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide-1 agonists protect pancreatic beta-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

What do we know about the secretion and degradation of incretin hormones?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Inhibition of dipeptidyl peptidase-IV activity by metformin enhances the antidiabetic effects of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Fatty heart, cardiac damage, and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Role of gastrointestinal hormones in postprandial reduction of bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Neuroprotective properties of GLP-1: theoretical and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Metformin protects against lipoapoptosis and enhances GLP-1 secretion from GLP-1-producing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Immunoreactive gastric inhibitory polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Cardiovascular effects of incretin-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Neuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Incretin-based therapies--review of the physiology, pharmacology and emerging clinical experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

International Union of Pharmacology. XXXV. The glucagon receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Dipeptidyl peptidase-4 inhibitors administered in combination with metformin result in an additive increase in the plasma concentration of active GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Inhibition of gastric inhibitory polypeptide signaling prevents obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-alpha (TNFalpha) and inhibits TNFalpha-induced apoptosis in insulin-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucose, metformin, and AICAR regulate the expression of G protein-coupled receptor members in INS-1 beta cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Attenuated GLP-1 secretion in obesity: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Potentiated beta-cell response to non-glucose stimuli in insulin-resistant C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Snapin mediates incretin action and augments glucose-dependent insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)--evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Hyperglycemia acutely lowers the postprandial excursions of glucagon-like Peptide-1 and gastric inhibitory polypeptide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

GIP biology and fat metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Combined analysis of 19 common validated type 2 diabetes susceptibility gene variants shows moderate discriminative value and no evidence of gene–gene interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Reduced Incretin Effect in Type 2 Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Glucagon-Like Peptide-1 Counteracts Oxidative Stress-Dependent Apoptosis of Human Cardiac Progenitor Cells by Inhibiting the Activation of the c-Jun N-terminal Protein Kinase Signaling Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F13813455.2013.812664

10.3109/13813455.2013.812664

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23859800%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference